Nav: Home

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs

February 19, 2019

An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made, according to a commentary in the Journal of the National Cancer Institute.

Compounding the problem is the growing number of cancer survivors age 65 years or older, who are more likely to have multiple health issues in addition to cancer-related medical needs, said Deborah K. Mayer, PhD, RN, AOCN, FAAN, director of cancer survivorship at the University of North Carolina Lineberger Comprehensive Cancer Center and the interim director of the National Cancer Institute's Office of Cancer Survivorship, who co-authored the commentary with Catherine M. Alfano, PhD, vice president of survivorship at the American Cancer Society.

"The number of new patients diagnosed with cancer is relatively flat, which is good news, and the number of survivors is growing exponentially which is also good news," said Mayer, who is also the Frances Hill Fox Distinguished Professor of Nursing at the UNC School of Nursing. "However, we are now faced with the challenge of how to create 'right-sized' follow-up care in oncology. How do we transition survivors in a rational way that ensures they receive the proper follow-up care in the most appropriate setting by the most appropriate providers?"

Studies have shown that people are waiting longer to receive cancer care in the United States, and research suggests it will continue to be an issue in the years ahead if changes are not made. An American Society of Clinical Oncology report in 2014 estimated there would be a shortage of 2,200 oncologists, or approximately a 10 percent gap in providers, by 2025.

To address this supply and demand gap, Mayer and Alfano recommend the development of risk-stratified cancer follow-up care, an approach others put forward a decade ago, and one that has been demonstrated to be effective in Australia, Canada and the United Kingdom.

"The goal of the risk-stratification model is to provide the best possible follow-up care for cancer survivors in the most appropriate setting," said Mayer. "This will reduce demand pressures on oncology practices by allowing the cancer specialists to focus on those who are most in need of their expertise."

Risk-stratification involves assigning a person to a level of care management, or a "clinical pathway," based on a health assessment of current and projected complexity of their medical needs and the type of healthcare provider their care requires. The pathways are developed using evidence-based care guidelines, an approach informed by clinical study outcomes. The health assessment covers a range of issues, including overall prognosis, likelihood of cancer recurrence and new secondary cancers, the potential risk and impact of cancer treatment side-effects - both chronic and late-stage, psychosocial and socio-economic challenges, and the person's ability to navigate the healthcare system and manage their own health needs.

Patients deemed to have a low-risk of immediate or late-stage complications would receive follow-up care from their primary care provider. Patients experiencing moderate and ongoing problems would be followed by advanced practice providers focusing on survivors or "shared care" with both primary care and oncology expertise. Patients with complex care issues, or who were expected to experience significant cancer-related issues in the future, would receive their follow-up care from a multi-disciplinary team of care givers, including an oncologist.

"For this approach to be successful, it needs to be shaped by the perspectives of patients and their families, clinicians, insurers, advocates and health policy experts," said Mayer. "We have research data that can help us determine the appropriate level of care intensity, but that alone doesn't paint the full picture."

Mayer said while no one care delivery model is perfect, doing nothing to address the systemic shortfall while waiting for the development of the ideal solution is not an option.

"We are facing a significant issue that will adversely affect access to care and the quality of care we provide cancer survivors," said Mayer. "The commentary identifies next steps in addressing this this growing care gap, which will become more complicated in time if we don't address now."
-end-


UNC Lineberger Comprehensive Cancer Center

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.